Tower Research Capital LLC (TRC) - EYEGATE PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of EYEGATE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$31,000
+1450.0%
13,832
+2836.7%
0.00%
Q4 2020$2,000
-66.7%
471
-67.3%
0.00%
Q3 2020$6,0001,4420.00%
Other shareholders
EYEGATE PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 3,346,601$12,182,0000.22%
Parkman Healthcare Partners LLC 75,647$275,0000.06%
Sterling Financial Planning, Inc. 1,171$4,0000.00%
Newbridge Financial Services Group, Inc. 1,000$4,0000.00%
UBS Group AG 399$1,0000.00%
TWO SIGMA INVESTMENTS, LP 27,061$99,0000.00%
OSAIC HOLDINGS, INC. 468$2,0000.00%
US BANCORP \DE\ 2,710$10,0000.00%
WELLS FARGO & COMPANY/MN 40$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of EYEGATE PHARMACEUTICALS INC shareholders